Advert - Novartis – Case AUTH/3725/1/23

For failing to update and recertify two documents hosted on a Novartis website to include up-to-date Entresto (sacubitril/valsartan) prescribing information, for the length of time one of the documents had been available with out-of-date prescribing information, and because the out-of-date prescribing information had the potential to impact patient safety, Novartis was ruled in breach of the following clauses of the 2021 Code:

 

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 5.1 - Failing to maintain high standards

Clause 12.1 - Failing to include up-to-date prescribing information